Sirisena, N.D.; Deen, K.I.; Mandawala, D.E.N.; Herath, P.; Dissanayake, V.H.W.
(Biomed Central, 2017)
Activating mutations in the KRAS gene, found in approximately 53% of metastatic colorectal cancer (mCRC) cases, can render epidermal growth factor receptor (EGFR) inhibitors ineffective. Regional differences in these ...